Pancreatic Cancer Research

Clinical trialPhase 2Unknown

The Effects of Neoadjuvant Metformin on Tumour Cell Proliferation and Tumour Progression in Pancreatic Ductal Adenocarcinoma

NCT02978547↗ ClinicalTrials.gov, retrieved 4 November 2026

Outcome
Outcome unknown
Phase
Phase 2
Status
Unknown
Study type
Interventional
Start
January 2019
Expected end
January 2021
Enrollment
20 participants
Sites
1
Primary outcomes
The effect of neoadjuvant metformin treatment on tumour cell proliferation in PDAC tumours
Sponsor
Other
Results posted
No
Last update
18 January 2018

These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.

Try

Papers 12